Intra-Cellular Therapies (ITCI) PT Raised to $74 at Mizuho Securities
Tweet
Share
E-mailGet Alerts ITCI Hot Sheet
Price: $131.87 --0%
Rating Summary:
9 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
9 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Mizuho Securities analyst Graig Suvannavejh raised the price target on Intra-Cellular Therapies (NASDAQ: ITCI) to $74.00 (from $66.00) while maintaining a Buy rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Kazia Therapeutics (KZIA) PT Raised to $40 at BTIG
- TETRA Technologies Inc. (TTI) PT Lowered to $10 at Northland
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
